Alzheimer's Disease—What the Practicing Clinician Needs to Know

Heckler MM : The fight against Alzheimer's disease. Am Psychologist 1985;40:1240-1244.

Terry RD , Katzman R. : Senile dementia of the Alzheimer type. Ann Neurol 1983;14:497-506.

Jenike MA : Handbook of Geriatric Psychopharmacology. Littleton, MA , PSG Publishing Co, 1985.

Wells CE : A deluge of dementia. Psychosomatics 1981;22: 836-840.

Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington, DC, American Psychiatric Association, 1985.

McKhann G. , Drachman D. , Folstein M. , et al: Clinical diagnosis of Alzheimer's disease. Neurology 1984;34:939-944.

Katzmen R. : Alzheimer's disease. N Engl J Med 1986;314: 964-967.

Wolozin BL , Pruchnicki A. , Dickson DW , et al: A neuronal antigen in the brains of Alzheimer patients. Science 1986;232: 648-651.

Reisberg B. , Ferris SH , DeLeon MJ , et al: The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.

Haase GR : Diseases presenting as dementia, in Wells CE (ed): Dementia. Philadelphia, FA Davis Co, 1977, pp 27-67.

Jellinger J. : Neuropathological agents and dementia. Acta Neurol Belg 1976;76:83-102.

Sourander P. , Sjogren H. : The concept of Alzheimer's disease and its clinical implications, in Wolstenholme GEW , O'Connor M (eds): Alzheimer's Disease and Related Conditions: A Ciba Foundation Symposium. London, Churchill Livingstone, 1970, pp 11-36.

Tomlinson BE , Blessed G. , Roth M. : Observations on the brains of non-demented old people. J Neurol Sci 1968;7:331-356.

Tomlinson BE , Blessed G. , Roth M. : Observations on the brains of demented old people. J Neurol Sci 1970;11:205-242.

Hachinski VC , Lassen NA , Marshall J. : Multi-infarct dementia. A cause of mental deterioration in the elderly. Lancet 1974;2: 207-210.

Lishman WA : Organic Psychiatry. London, Blackwell Scientific Publications, 1978.

Wells CE : Diagnostic evaluation and treatment in dementia, in Wells CE (ed): Dementia, ed 2. Philadelphia, FA Davis Co, 1977, pp 247-273.

Cummings JL , Benson DR : Subcortical dementia: Review of an emerging concept. Arch Neurol 1984;41:874-879.

Cummings JL , Benson DR : Dementia: A Clinical Approach. Stoneham, MA, Butterworth Inc, 1983.

Joynt RF , Shoulson I. : Dementia, in Heilman KM , Valenstein E (eds): Clinical Neuropsychology. Oxford, England, Oxford University Press, 1975, pp 475-502.

Huber SJ , Shuttleworth EC , Paulson GW , et al: Cortical vs subcortical dementia. Arch Neurol 1986;43:392-394.

Mayeux R. , Stern Y. , Rosen J. , et al: Is "subcortical dementia" a recognizable clinical entity? Ann Neurol 1983;10:278-284.

Manuelidis EE , Kim JH , Mericangas JR , et al: Transmission to animals of Creutzfeldt-Jakob disease from human blood. Lancet 1985;2:896-897.

Salzman C (ed): Clinical Geriatric Psychopharmacology. New York, McGraw-Hill Book Co, 1984.

Jenike MA : Management of Alzheimer's disease, in Gorroll AH , May L , Mulley A , (eds): Primary Care Medicine, ed 2. Philadelphia, JB Lippincott Co, 1987, pp 755-759.

Bartus RT , Dean RL , Beer R. , et al: The cholinergic hypothesis of geriatric memory dysfunction. Science 1982;217:408-416. 27. Jenike MA : Alzheimer's disease. Sci Am Med 1986;9:1-4.

Thal L. , Masur D. , Fuld P. , et al: Memory improvement with oral physostigmine and lecithin in Alzheimer's disease, in Katzman R (ed): Banbury Report 15: Biological Aspects of Alzheimer's Disease. New York, Cold Spring Harbor Laboratory, 1983, pp 461-469.

Jenike MA , Albert MS , Heller H. , et al: Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type (Alzheimer's disease): a double-blind, placebo-controlled trial. (Submitted for publication.)

Mohs RC , Davis BM , Johns CA , et al: Oral physostigmine treatment of patients with Alzheimer's disease . Am J Psychiatry 1985;142:28-33.

Summers WK , Majovski LV , Marsh GM , et al: Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 1986 ;315:1241-1245.

Harbaugh RE , Roberts DW , Coombs DW , et al: Preliminary report: Intracranial cholinergic drug infusion in patients with Alzheimer's disease. Neurosurgery 1984;15:514-517.

Spiegel R. , Huber F. , Koberle S. : A controlled long-term study of ergoloid mesylates (hydergine) in healthy volunteers. J Am Geriatr Soc 1983;31:549-555.

Reisberg B. , Ferris SH , Gershon S. : An overview of pharmacologic treatment of cognitive decline in the aged. Am J Psychiatry 1981;138:593-600.

Hollister LE , Yesavage J. : Ergoloid mesylates for senile dementia: Unanswered questions. Ann Intern Med 1984;100: 894-898.

Crook T , Cohen G (eds): Physicians' Handbook on Psychotherapeutic Drug Use in the Elderly . New Canaan, Conn, Mark Powley Associates, Inc, 1981.

Chelation Therapy, In Harvard Med School Health Lett Boston, MA, July 1984.

Jenike MA : Monoamine oxidase inhibitors in elderly depressed patients. J Am Geriatr Soc 1984;32:571-575.

Jenike MA : MAO inhibitors as treatment for depressed patients with primary degenerative dementia. Am J Psychiatry 1985;142:763-764.

Mace NI , Rabins PV : The 36-Hour Day. Baltimore, The Johns Hopkins University Press, 1981.

Rabins PV : Management of dementia in the family context. Psychosomatics 1984;25:369-375.

Uhlmann RF , Larson EB , Koepsell TD : Hearing impairment and cognitive decline in senile dementia of the Alzheimer's type. J Am Geriatr Soc 1986;34:207-210.